{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:08:04Z","timestamp":1778818084450,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.thromres.2011.02.010","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T09:50:04Z","timestamp":1302861004000},"page":"513-517","source":"Crossref","is-referenced-by-count":20,"title":["Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?"],"prefix":"10.1016","volume":"127","author":[{"given":"James D.","family":"Douketis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2011.02.010_bb0005","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"S\u00f8rensen","year":"2009","journal-title":"Lancet"},{"issue":"6 Suppl.","key":"10.1016\/j.thromres.2011.02.010_bb0010","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1378\/chest.08-0675","article-title":"The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"133","author":"Douketis","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2011.02.010_bb0015","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.02.010_bb0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ahj.2009.11.025","article-title":"Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study","volume":"159","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2011.02.010_bb0025","doi-asserted-by":"crossref","first-page":"776S","DOI":"10.1378\/chest.08-0685","article-title":"The primary and secondary prevention of coronary artery disease. American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Becker","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2011.02.010_bb0030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.106.177031","article-title":"ACC\/AHA\/ESC Guidelines for the management of patients with atrial fibrillation - executive summary","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2011.02.010_bb0035","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1378\/chest.06-2374","article-title":"Warfarin and antiplatelet combination use among commercially insured patients enrolled in a anticoagulation management service","volume":"131","author":"Johnson","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2011.02.010_bb0040","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2011.02.010_bb0045","author":"National Heart, Lung and Blood Institute"},{"key":"10.1016\/j.thromres.2011.02.010_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archinte.167.2.117","article-title":"Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease","volume":"167","author":"Dentali","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2011.02.010_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial","volume":"360","author":"Van Es","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2011.02.010_bb0060","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Arnesen. Warfarin, aspirin, or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.02.010_bb0065","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ahj.2006.06.024","article-title":"Risk and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials","volume":"152","author":"Flacker","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2011.02.010_bb0070","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1378\/chest.07-2627","article-title":"Outcomes associated with combined antiplatelet and anticoagulant therapy","volume":"133","author":"Johnson","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2011.02.010_bb0075","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2011.02.010_bb0080","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2011.02.010_bb0085","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archinte.153.13.1557","article-title":"Bleeding complications in oral anticoagulation therapy","volume":"153","author":"Van der Meer","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2011.02.010_bb0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2007.69","article-title":"Patient outcomes after deep vein thrombosis and pulmonary embolism: The Worcester Venous Thromboembolism Study","volume":"168","author":"Spencer","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2011.02.010_bb0095","doi-asserted-by":"crossref","first-page":"893","DOI":"10.7326\/0003-4819-139-11-200312020-00007","article-title":"Clinical impact of Bleeding in patients taking oral anticoagulation therapy for venous thromboembolism: a meta analysis","volume":"139","author":"Linkins","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2011.02.010_bb0100","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","article-title":"Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism","volume":"152","author":"Carrier","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2011.02.010_bb0105","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11239-010-0462-8","article-title":"Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction","volume":"30","author":"Amlani","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2011.02.010_bb0110","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.109.872630","article-title":"Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials","volume":"120","author":"Eikelboom","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2011.02.010_bb0115","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archinte.166.8.853","article-title":"Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin","volume":"166","author":"Douketis","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2011.02.010_bb0120","doi-asserted-by":"crossref","first-page":"593S","DOI":"10.1378\/chest.08-0724","article-title":"Valvular and structural heart disease. American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Salem","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2011.02.010_bb0125","first-page":"450","article-title":"ACC\/AHA 2006 Guidelines for the management of patients with valvular heart disease - executive summary","volume":"114","author":"Bonow","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2011.02.010_bb0130","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"6 Suppl.","key":"10.1016\/j.thromres.2011.02.010_bb0135","doi-asserted-by":"crossref","first-page":"670S","DOI":"10.1378\/chest.08-0691","article-title":"Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Harrington","year":"2008","journal-title":"Chest"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811000776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811000776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T15:25:10Z","timestamp":1543850710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384811000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0049384811000776"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.02.010","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}